Procedures for the assessment of endocrine disruptors in the BASTA system are based on a methodology described in the report “Guidance document for handling criteria for endocrine disruptors in the construction industry” developed by the IVL Swedish Environmental Research Institute and representatives from the construction industry.
B2369 Guidance Document Endocrine Disrupters
A transition period will be applied during the period 1/1 2020 to 1/7 2020 to adapt to the new criterion. The EDS database, which has so far been the basis for criterion 5, continues to apply until 1/7 2020, but thereafter the EDS database will only be included in the BASTA system as an information requirement.
The following substances are under evaluation:
DINP CAS-number 68515-48-0, 28553-12-0
DIDP CAS-number 68515-49-1, 26761-40-0
DPHP CAS-number 53306-54-0
Products already registered containing CAS-number 68515-49-1 may remain registered during the evalutaion period.
DOTO, Dioctyltin oxide CAS-number 870-08-6
Products already registered containing CAS-number 870-08-6 may remain registered during the evalutaion period
A. Substances assessed as endocrine disruptors as defined by the EU *
B. Substances that are listed on three selected lists and where there are indications that the substances are endocrine disruptors or alternatively that they are being investigated within the EU.
C. The possibility of questioning the substances listed under B if there are scientifically robust arguments. Mandatory documentation requirements and approval process.
Figure 1. Decision tree for the management of endocrine disruptors.
